Skip to main content

Advertisement

Log in

Women and Vulnerability to HAART Non-Adherence: A Literature Review of Treatment Adherence by Gender from 2000 to 2011

  • Behavioral Aspects of HIV Management (Ralph J. DiClemente and Jennifer Brown, Section Editors)
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

A literature review of original research articles on adherence to antiretroviral therapy (ART) in developed countries, covering January 2000 to June 2011, was conducted to determine if gender differences exist in the prevalence of nonadherence to ART. Of the 1,255 articles reviewed, only 189 included data on the proportion of the study population that was adherent and only 57 (30.2%) of these reported proportional adherence values by gender. While comparing articles was challenging because of varied reporting strategies, women generally exhibit poorer adherence than men. Thirty of the 44 articles (68.2%) that reported comparative data on adherence by gender found women to be less adherent than men. Ten articles (17.5%) reported significant differences in proportional adherence by gender, nine of which showed women to be less adherent than men. These findings suggest that in multiple studies from developed countries, female gender often predicts lower adherence. The unique circumstances of HIV–positive women require specialized care to increase adherence to ART.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.

    PubMed  CAS  Google Scholar 

  2. Maggiolo F, Airoldi M, Kleinloog HD, et al. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients. HIV Clin Trials. 2007;8:282–92.

    Article  PubMed  Google Scholar 

  3. Roux P, Carrieri MP, Cohen J, et al. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clin Infect Dis. 2009;49:1433–40.

    Article  PubMed  Google Scholar 

  4. Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84:188–94.

    Article  PubMed  Google Scholar 

  5. Sullivan PS, Campsmith ML, Nakamura GV, et al. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS One. 2007;6:e552.

    Article  Google Scholar 

  6. Parsons JT, Rosof E, Mustanski B. Patient-related factors predicting HIV medication adherence among men and women with alcohol problems. J Health Psychol. 2007;12:357–70.

    Article  PubMed  Google Scholar 

  7. McDonnell Holstad MK, Pace JC, Anindya K, et al. Factors associated with adherence to antiretroviral therapy. J Assoc Nurses AIDS Care. 2006;17:4–15.

    Article  Google Scholar 

  8. Kuyper LM, Wood E, Montaner JSG, et al. Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort. J Acquir Immune Defic Syndr. 2004;37:1470–6.

    Article  PubMed  Google Scholar 

  9. • Kacanek D, Jacobson DL, Spiegelman D, et al. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the nutrition for healthy living study. J Acquir Immune Defic Syndr. 2010;53:266–72. This study showed a significant relationship between incident depression and suboptimal ART adherence. A significantly higher proportion of women than men developed depressive symptoms and were less likely to be adherent.

    Article  PubMed  Google Scholar 

  10. Kumar V, Encinosa W. Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients. Psychiatr Q. 2009;80:131–41.

    Article  PubMed  Google Scholar 

  11. Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21:1175–83.

    Article  PubMed  Google Scholar 

  12. Sledjeski EM, Delahanty DL, Bogart LM. Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV. AIDS Patient Care STDS. 2005;19:728–36.

    Article  PubMed  Google Scholar 

  13. Phillips KD, Moneyham L, Murdaugh C, et al. Sleep disturbance and depression as barriers to adherence. Clin Nurs Res. 2005;14:273–93.

    Article  PubMed  Google Scholar 

  14. Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394–402.

    Article  PubMed  Google Scholar 

  15. Gonzalez JS, Penedo FJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004;23:413–8.

    Article  PubMed  Google Scholar 

  16. Fielden SJ, Rusch MLA, Yip B, et al. Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naïve patients started on HAART. J Int Assoc Physicians AIDS Care. 2008;7:238–44.

    Article  Google Scholar 

  17. •• Ubbiali A, Donati D, Chiorri C, et al. Prediction of adherence to antiretroviral therapy: can patients’ gender play some role? An Italian pilot study. AIDS Care 2008;20:571–5. This study examines the psychological characteristics of both non-adherent and adherent men and women, with a focus on relational style. Differences between genders were observed, with non-adherent women having a greater preoccupation with relationships and need for approval, while non-adherent men were found to be less relationship-oriented.

    Article  PubMed  CAS  Google Scholar 

  18. Sayles JN, Wong MD, Kinsler JJ, et al. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009;24:1101–8.

    Article  PubMed  Google Scholar 

  19. Rintamaki LS, Davic TC, Skripkauskas S, et al. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006;20:359–68.

    Article  PubMed  Google Scholar 

  20. Leserman J, Ironson G, O’Cleirigh C, et al. Stressful life events and adherence to HIV. AIDS Patient Care STDS. 2008;22:403–11.

    Article  PubMed  Google Scholar 

  21. Wood SA, Tobias C, McCree J. Medication adherence for HIV positive women caring for children: in their own words. AIDS Care. 2004;16:909–13.

    Article  PubMed  CAS  Google Scholar 

  22. Mugavero MJ, Raper JL, Reif S, et al. Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study. Psychosom Med. 2009;9:920–6.

    Article  Google Scholar 

  23. Shin S, Muñoz M, Espiritu B, et al. Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru. J Int Assoc Physicians AIDS Care. 2008;7:74–81.

    Article  Google Scholar 

  24. Knowlton AR, Arnsten JH, Eldred LJ, et al. Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors. AIDS Patient Care STDS. 2010;24:421–8.

    Article  PubMed  Google Scholar 

  25. Pulvirenti JJ, Glowacki R, Muppiddi U, et al. Hospitalized HIV-infected patients in the HAART era: a view from the inner city. AIDS Patient Care STDS. 2003;17:565–73.

    Article  PubMed  Google Scholar 

  26. Moore DM, Zhang W, Genebat M, et al. Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme. HIV Med. 2010;11:299–307.

    Article  PubMed  CAS  Google Scholar 

  27. Carmody ER, Diaz T, Starling P, et al. An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic. Trop Med Int Health. 2003;8:378–85.

    Article  PubMed  Google Scholar 

  28. Yuan Y, L’Italien G, Mukherjee J, et al. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Med. 2006;7:156–62.

    Article  PubMed  CAS  Google Scholar 

  29. Lima VD, Bangsberg DR, Harrigan PR, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr. 2010;55:460–5.

    Article  PubMed  CAS  Google Scholar 

  30. Jhaveri MA, Browning SR, Bush H, et al. Comparison of 3-drug versus 4 drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007. J Int Assoc Physicians AIDS Care. 2009;8:299–307.

    Article  Google Scholar 

  31. Turner BJ, Laine C, Cosler L, et al. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18:248–57.

    Article  PubMed  Google Scholar 

  32. Applebaum AJ, Richardson MA, Brady SM, et al. Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. AIDS Behav. 2009;13:60–5.

    Article  PubMed  Google Scholar 

  33. Sherr L, Lampe F, Norwood S, et al. Successive switching of antiretroviral therapy is associated with high psychological and physical burden. Int J STD AIDS. 2007;18:700–4.

    Article  PubMed  Google Scholar 

  34. Wood E, Hogg RS, Yip B, et al. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts ≥200 cells/μl. AIDS. 2006;20:1117–23.

    Article  PubMed  Google Scholar 

  35. Barfod TS, Gerstoft J, Rodkjaer L, et al. Patients’ answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: a cross-sectional survey. AIDS Patient Care STDS. 2005;19:317–25.

    Article  PubMed  Google Scholar 

  36. Carrieri MP, Raffi F, Lewden C, et al. Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antivir Ther. 2003;8:585–94.

    PubMed  CAS  Google Scholar 

  37. Roca B, Gómez CJ, Arnedo A. A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir in treatment-experienced HIV-infected patients. AIDS. 2000;14:157–61.

    Article  PubMed  CAS  Google Scholar 

  38. Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26:488–95.

    Article  PubMed  Google Scholar 

  39. Remien RH, Bastos FI, Terto Jr V, et al. Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil. AIDS Care. 2007;19:740–8.

    Article  PubMed  CAS  Google Scholar 

  40. Johnson MO, Charlebois E, Morin SF, et al. Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage. 2005;29:193–205.

    Article  PubMed  Google Scholar 

  41. Bouhnik A-D, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr. 2002;31:S149–53.

    Article  PubMed  Google Scholar 

  42. Sherr L, Lampe FC, Clucas C, et al. Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010;22:939–45.

    Article  PubMed  CAS  Google Scholar 

  43. Montaner J. Treatment as prevention—a double hat-trick. Lancet. 2011;378:208–9.

    Article  PubMed  Google Scholar 

  44. Kerr T, Walsh J, Lloyd-Smith E, Wood E. Measuring adherence to highly active antiretroviral therapy: implications for research and practice. Curr HIV/AIDS Rep. 2005;2:200–5.

    Article  PubMed  Google Scholar 

  45. United Nations Development Program: Human development index and its components. Available at http://hdr.undp.org/en/statistics/. Accessed May 2011.

  46. Kyser M, Buchacz K, Bush TJ, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS Care. 2011;23:601–11.

    Article  PubMed  Google Scholar 

  47. Royal SW, Kidder DP, Patrabansh S, et al. Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV. AIDS Care. 2009;21:448–55.

    Article  PubMed  Google Scholar 

  48. Miguez-Burbano MJ, Espinoza L, Lewis JE. HIV treatment adherence and sexual functioning. AIDS Behav. 2008;12:78–85.

    Article  PubMed  Google Scholar 

  49. Sherr L, Lampe F, Norwood S, et al. Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity. AIDS Care. 2008;20:442–8.

    Article  PubMed  Google Scholar 

  50. Beach MC, Duggan PS, Moore RD. Is patients’ preferred involvement in health decisions related to outcomes for patients with HIV? J Gen Intern Med. 2007;22:1119–24.

    Article  PubMed  Google Scholar 

  51. Peretti-Watel P, Spire B, Lert F, et al. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug Alcohol Depend. 2006;82:S71–9.

    Article  PubMed  Google Scholar 

  52. Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med. 2006;62:2420–33.

    Article  PubMed  CAS  Google Scholar 

  53. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133–40.

    Article  PubMed  Google Scholar 

  54. Deloria-Knoll M, Chmiel JS, Moorman AC, et al. Factors related to and consequences of adherence to antiretroviral therapy in an ambulatory HIV-infected patient cohort. AIDS Patient Care STDS. 2004;18:721–7.

    Article  PubMed  Google Scholar 

  55. Kleeberger CA, Buechner J, Palella F, et al. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS. 2004;18:683–8.

    Article  PubMed  Google Scholar 

  56. Palepu A, Tyndall MW, Chan K, et al. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther. 2004;9:713–9.

    PubMed  Google Scholar 

  57. Sharpe TT, Lee LM, Nakashima AK, et al. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. J Community Health. 2004;29:117–27.

    Article  PubMed  Google Scholar 

  58. Fong OW, Ho CF, Fung LY, et al. Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. HIV Med. 2003;4:133–8.

    Article  PubMed  CAS  Google Scholar 

  59. Spire B, Duran S, Souville M, et al. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med. 2002;54:1481–96.

    Article  PubMed  Google Scholar 

  60. Wagner GJ, Remien RH, Carballo-Diéguez A, Dolezal C. Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples. AIDS Care. 2002;14:105–9.

    Article  PubMed  CAS  Google Scholar 

  61. Brigido LFM, Rodrigues R, Casseb J, et al. Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil. AIDS Patient Care STDS. 2001;15:587–93.

    Article  PubMed  CAS  Google Scholar 

  62. Duran S, Spire B, Raffi F, et al. Self-reported symptoms after initiation of a protease inhibitor on HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials. 2001;2:38–45.

    Article  PubMed  CAS  Google Scholar 

  63. Gross R, Yip B, Re LR, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006;15:1108–14.

    Article  Google Scholar 

  64. Plankey M, Bacchetti P, Chengshi J, et al. Self-perception of body fat changes and HAART adherence in the Women’s Interagency HIV Study. AIDS Behav. 2009;13:53–9.

    Article  PubMed  Google Scholar 

  65. Fumaz CR, Muñoz-Moreno JA, Moltó J, et al. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs. AIDS Care. 2008;20:796–805.

    Article  PubMed  CAS  Google Scholar 

  66. Kapadia F, Vlahov D, Wu Y, et al. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse. 2008;34:161–70.

    Article  PubMed  Google Scholar 

  67. Merenstein DJ, Schneider MF, Cox C, et al. Association between living with children and adherence to highly active antiretroviral therapy in the Women’s Interagency HIV Study. Pediatrics. 2008;121:e787–93.

    Article  PubMed  Google Scholar 

  68. Graham J, Bennett IM, Holmes WC, Gross R. Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV infected individuals. AIDS Behav. 2007;11:385–92.

    Article  PubMed  Google Scholar 

  69. Vaz MJR, Barros SMO, Palacios R, et al. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. Int J STD AIDS. 2007;18:28–32.

    Article  PubMed  Google Scholar 

  70. Braitstein P, Justice A, Bangsberg DR, et al. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS. 2006;20:323–31.

    Article  PubMed  Google Scholar 

  71. Södergård B, Halvarsson M, Tully MP, et al. Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther. 2006;31:605–15.

    Article  PubMed  Google Scholar 

  72. Anastos K, Schneider MF, Gange SJ, et al. The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. J Acquir Immune Defic Syndr. 2005;39:537–44.

    PubMed  CAS  Google Scholar 

  73. de Bonolo PF, César CC, Acúrcio FA, et al. Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil. AIDS. 2005;19:S5–13.

    Article  Google Scholar 

  74. Halkitis PN, Kutnick AH, Slater S. The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states. J Health Psychol. 2005;10:545–58.

    Article  PubMed  Google Scholar 

  75. Kerr T, Palepu A, Barnes G, et al. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir Ther. 2004;9:407–14.

    PubMed  Google Scholar 

  76. Mohammed H, Kieltyka L, Richardson-Alston G, et al. Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDS. 2004;18:289–96.

    Article  PubMed  Google Scholar 

  77. Palepu A, Horton NJ, Tibbetts N, et al. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004;99:361–8.

    Article  PubMed  Google Scholar 

  78. Delgado J, Heath KV, Yip B, et al. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill. Antivir Ther. 2003;8:471–8.

    PubMed  Google Scholar 

  79. Parruti G, Manzoli L, Toro PM, et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse. AIDS Patient Care STDS. 2006;20:48–57.

    Article  PubMed  CAS  Google Scholar 

  80. García de Olalla P, Knobel H, Carmona A, et al. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30:105–10.

    PubMed  Google Scholar 

  81. Witteveen E, van Ameijden EJC. Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence. Subst Use Misuse. 2002;37:1905–25.

    Article  PubMed  Google Scholar 

  82. Martín J, Escobar I, Rubio R, et al. Study of the validity of a questionnaire to assess the adherence to therapy in patients infected by HIV. HIV Clin Trials. 2001;2:31–7.

    Article  PubMed  Google Scholar 

  83. Moatti JP, Carrieri MP, Spire B, et al. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS. 2000;14:151–5.

    Article  PubMed  CAS  Google Scholar 

  84. Duggan JM, Locher A, Fink B, et al. Adherence to antiretroviral therapy: a survey of factors associated with medication usage. AIDS Care. 2009;21:1141–7.

    Article  PubMed  Google Scholar 

  85. Cardarelli R, Weis S, Adams E, et al. General health status and adherence to antiretroviral therapy. J Int Assoc Physicians AIDS Care. 2008;7:123–9.

    Article  Google Scholar 

  86. Garcia R, Badaró R, Netto EM, et al. Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients. AIDS Res Hum Retroviruses. 2006;22:1248–52.

    Article  PubMed  CAS  Google Scholar 

  87. Moralejo L, Inés S, Marcos M, et al. Factors influencing adherence to highly active antiretroviral therapy in Spain. Curr HIV Res. 2006;4:221–7.

    Article  PubMed  CAS  Google Scholar 

  88. Russell J, Krantz S, Neville S. The patient-provider relationship and adherence to highly active antiretroviral therapy. J Assoc Nurses AIDS Care. 2004;15:40–7.

    Article  PubMed  Google Scholar 

  89. Haug NA, Sorensen JL, Lollo ND, et al. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial. AIDS Care. 2005;17:1022–9.

    Article  PubMed  CAS  Google Scholar 

  90. Sidat M, Fairley C, Grierson J. Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study. AIDS Patient Care STDS. 2007;21:509–20.

    Article  PubMed  Google Scholar 

  91. Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006;18:904–10.

    Article  PubMed  CAS  Google Scholar 

  92. Stevens PE, Hildebrandt E. Pill taking from the perspective of HIV-infected women who are vulnerable to antiretroviral treatment failure. Qual Health Res. 2009;19:593–604.

    Article  PubMed  Google Scholar 

  93. Lewis MP, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care. 2006;18:140–8.

    Google Scholar 

Download references

Disclosure

Dr. Bangsberg was supported by K-24 MH87227.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert S. Hogg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puskas, C.M., Forrest, J.I., Parashar, S. et al. Women and Vulnerability to HAART Non-Adherence: A Literature Review of Treatment Adherence by Gender from 2000 to 2011. Curr HIV/AIDS Rep 8, 277–287 (2011). https://doi.org/10.1007/s11904-011-0098-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-011-0098-0

Keywords

Navigation